化妆品

72 项原料.

按子分类浏览

About this category

The Cosmetics glossary covers INCI-recognized cosmetic ingredients used in Japanese personal care manufacturing, spanning plant extracts, fermented derivatives, marine ingredients, oils, surfactants, and quasi-drug actives. The Japanese cosmetic ingredient catalogue is one of the most diverse in the world, combining ingredients with thousands of years of traditional cosmetic use (rice bran, camellia oil, seaweed) with cutting-edge biotechnology actives (recombinant collagen, exosome-style derivatives, post-biotic ferments). This glossary aims to provide neutral, dictionary-style definitions of how each ingredient is produced, what its INCI name is, what concentration ranges are typical, and how it is regulated in Japan and major export markets.

Historically, Japanese cosmetic ingredients evolved from Heian-period (794–1185) court rituals — where rice bran (komenuka) was used as a cleansing powder and camellia (Camellia japonica) seed oil dressed hair — through Edo-period (1603–1868) refinement of geisha-grade preparations to the modern era of industrial chemistry. Shiseido, founded in 1872 as Japan's first Western-style pharmacy, introduced laboratory methods to cosmetic ingredient development in the early 20th century. The post-war period saw the introduction of fermentation-based actives, beginning with Pitera-style yeast filtrates in the 1970s and continuing through marine collagen peptides in the 1990s and post-biotic ferments in the 2010s. Each generation of innovation built on the preceding traditions rather than replacing them: a contemporary J-beauty serum might contain a 17th-century camellia oil base, a 1970s Galactomyces ferment, and a 2020s recombinant peptide.

In the modern marketplace, INCI nomenclature provides the international common reference for ingredient identity. Japan participates in the INCI system through the Japan Cosmetic Industry Association (JCIA), which maintains the Japanese Standards of Cosmetic Ingredients (JSCI) — the equivalent of the US Cosmetic Ingredient Review and the EU CosIng database. JSCI lists over 18,000 ingredients with Japanese names and INCI cross-references. The Pharmaceuticals and Medical Devices Agency (PMDA) maintains parallel quasi-drug positive and negative lists. For each ingredient in this glossary, definitions cover: INCI name, common Japanese trade name(s), botanical source or chemical synthesis route, typical use level, principal cosmetic functions (e.g. emollient, antioxidant, brightening), regulatory status in JP/EU/US/CN/KR, and notable clinical evidence where available.

Users of this glossary include international formulators verifying the identity of a Japanese supplier's product, regulatory specialists mapping a JSCI name to an INCI/CosIng entry, R&D teams researching new ingredient categories, and education-focused readers seeking neutral background on Japanese beauty science. Each entry is written to be self-contained but includes cross-references to related ingredients in other glossary categories (Food, Supplements, Traditional) and to relevant Sourcing categories where suppliers are listed. We avoid marketing language and do not rank or recommend ingredients; the goal is precise definitions buyers can use as a reference document.

For users new to Japanese cosmetic ingredients, we suggest beginning with the most commonly encountered categories — fermented yeast filtrates, marine collagen, plant extracts (camellia, rice bran, green tea), and quasi-drug actives (tranexamic acid, arbutin, niacinamide) — before moving into specialty marine, kampo-derived, and biotechnology-derived ingredients. Where possible, definitions cite original Japanese-language sources alongside English-language regulatory references, and note where INCI naming conventions differ from Japanese trade or scientific naming.

Key facts

Nomenclature framework
INCI (International Nomenclature of Cosmetic Ingredients) is the global standard; Japan maintains the Japanese Standards of Cosmetic Ingredients (JSCI) administered by JCIA, listing over 18,000 ingredients with Japanese-INCI cross-references.
Heritage
Japanese cosmetic ingredients span Heian-period (794–1185) traditional materials such as rice bran and camellia oil, through Edo-period (1603–1868) geisha-grade preparations, to modern fermentation and biotechnology actives industrialized from the 1970s onward.
Regulatory framework
Cosmetics are regulated under Japan's Pharmaceuticals and Medical Devices Act (PMD Act, 薬機法); ordinary cosmetics use a positive/negative list with self-certification, while quasi-drugs (iyakubugaihin, 医薬部外品) require pre-market approval from PMDA.
Ingredient categories covered
Plant extracts (botanical actives, oils), fermented derivatives (yeast filtrates, post-biotics), marine ingredients (collagen, fucoidan, algae actives), surfactants, emollients, polymers, preservatives, and quasi-drug actives (whitening, anti-acne, anti-aging).
Cross-market mapping
Each glossary entry where applicable maps INCI name to JSCI registration, EU CosIng entry, US PCPC dictionary listing, China IECIC 2021 status, and Korea KCIA registration to support cross-border formulation work.

Where to start

Editor's picks for first-time visitors to this category.

Regulatory at a glance

Cosmetic ingredients are regulated under Japan's Pharmaceuticals and Medical Devices Act (PMD Act), which divides personal care products into ordinary cosmetics and quasi-drugs. Ordinary cosmetics may be self-certified by the manufacturer using a positive/negative list framework; the PMDA maintains lists of prohibited and restricted ingredients along with a positive list of UV filters and preservatives. Quasi-drug actives require pre-market approval and substantial efficacy and safety dossiers. Importers should be aware that several ingredients freely usable in EU or US cosmetics — including some peptide actives, certain plant extracts, and select preservative systems — are restricted or unlisted in Japan, requiring supplier consultation before formulation work begins. For cross-border alignment, buyers should map each ingredient against EU CosIng (which integrates with Annexes II–VI of EC Regulation 1223/2009), the US Personal Care Products Council ingredient dictionary (with awareness of MoCRA Facility Registration and Adverse Event Reporting requirements as of December 2023), China's IECIC 2021 and 2024 supplements (under the Cosmetic Supervision and Administration Regulation, CSAR), and South Korea's KCIA / KFDA framework. Halal-certified cosmetic ingredients are increasingly required for Southeast Asian and Middle Eastern markets; the Japan Halal Association and Malaysia Chapter of JAKIM offer certification accepted in most major Muslim-majority markets.

全部化妆品

OEM 采购方常见问题

Q. 日本化妆品原料与其他亚洲来源原料有何不同？

日本化妆品原料兼具悠久的制造历史（往往50–100年以上）、对JCIA《日本化妆品成分标准》(JSCI) 的严格遵守，以及将一般化妆品与准药物 (薬用化粧品) 分离的法规框架。许多植物活性成分具有县级可追溯性，并以承载日本产地信号的特定INCI名称在CosIng中收录。

信息来源

Q. 在日本，「化妆品」与「准药物」原料有何区别？

在日本《医药品医疗器械法》(薬機法) 下，「化妆品」(化粧品) 原料用于以温和作用进行清洁、美化或调整外观。「准药物」(医薬部外品) 活性成分具有美白、抗痘或生发等已批准功效宣称，并需额外注册。许多日本品牌定位宣称（如「美白」、「シワ改善」）只有在活性成分为准药物原料时才在日本合法。

信息来源

  • MHLW — Pharmaceuticals and Medical Devices Act (薬機法)
  • MHLW Quasi-Drug Active Ingredient Standards
Q. 日本化妆品原料是否在欧盟CosIng和美国INCI词典中收录？

大多数成熟的日本化妆品原料已在CosIng（欧盟INCI数据库）和个人护理产品理事会INCI词典中收录。较新的或专有原料可能需要INCI名称申请。在为欧盟/美国市场配方前，请始终确认INCI存在。

信息来源

Q. 哪些日本化妆品原料受中国NMPA注册约束？

中国NMPA维护IECIC（已使用化妆品原料目录）——只有列入目录的原料才能在无单独备案的情况下使用。许多日本植物提取物，特别是不太常见的物种，未被列入IECIC，需要新原料注册（耗时数年的过程）。山茶油、透明质酸及标准植物原料等常见原料被广泛收录。

信息来源

  • China NMPA IECIC (Inventory of Existing Cosmetic Ingredients in China)